The company has demonstrably boosted the development of an new solution for amyloid heart disease, utilizing Attruby. Early clinical information reveals promising benefits for individuals diagnosed with a serious condition. The effort highlights BridgeBio's commitment to treating unmet healthcare requirements in this heart space. Attrub… Read More